Cargando…

A Pan-GTPase Inhibitor as a Molecular Probe

Overactive GTPases have often been linked to human diseases. The available inhibitors are limited and have not progressed far in clinical trials. We report here a first-in-class small molecule pan-GTPase inhibitor discovered from a high throughput screening campaign. The compound CID1067700 inhibits...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Lin, Guo, Yuna, BasuRay, Soumik, Agola, Jacob O., Romero, Elsa, Simpson, Denise S., Schroeder, Chad E., Simons, Peter, Waller, Anna, Garcia, Matthew, Carter, Mark, Ursu, Oleg, Gouveia, Kristine, Golden, Jennifer E., Aubé, Jeffrey, Wandinger-Ness, Angela, Sklar, Larry A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4527730/
https://www.ncbi.nlm.nih.gov/pubmed/26247207
http://dx.doi.org/10.1371/journal.pone.0134317
Descripción
Sumario:Overactive GTPases have often been linked to human diseases. The available inhibitors are limited and have not progressed far in clinical trials. We report here a first-in-class small molecule pan-GTPase inhibitor discovered from a high throughput screening campaign. The compound CID1067700 inhibits multiple GTPases in biochemical, cellular protein and protein interaction, as well as cellular functional assays. In the biochemical and protein interaction assays, representative GTPases from Rho, Ras, and Rab, the three most generic subfamilies of the GTPases, were probed, while in the functional assays, physiological processes regulated by each of the three subfamilies of the GTPases were examined. The chemical functionalities essential for the activity of the compound were identified through structural derivatization. The compound is validated as a useful molecular probe upon which GTPase-targeting inhibitors with drug potentials might be developed.